shutterstock_728117296_-nicolo-zangirolami

Nicolo Zangirolami / Shutterstock.com

30 September 2019BiotechnologyMaxim Sobolev

Secondary patents: Moscow mewl

The Russian IP ombudsman Anatoly Semenov has written to the Russian lower house, the State Duma, drawing its attention to the increasing number of patent conflicts among pharmaceutical manufacturers in Russia and urged the Duma to legislate to address the issue.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Kilpatrick adds ‘seasoned litigator’ as trademark partner

Bayer, Orion take on Indian generic over $117bn drug

BMS unit loses cell therapy patent at European Patent Office

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Bankruptcy judge approves $305m sale of genetics testing company

Broad Institute wins appeal to restore CRISPR patent in Europe

WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations

Regeneron hits Amgen over its blockbuster eye disease treatment